Literature DB >> 24903344

Reply: 'a review of central retinal artery occlusion: clinical presentation and management'.

D Varma1, A W Lee1, C S Chen2.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24903344      PMCID: PMC4194322          DOI: 10.1038/eye.2014.119

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  8 in total

Review 1.  A review of central retinal artery occlusion: clinical presentation and management.

Authors:  D D Varma; S Cugati; A W Lee; C S Chen
Journal:  Eye (Lond)       Date:  2013-03-08       Impact factor: 3.775

2.  Concerning central retinal artery occlusion (CRAO) and cerebral stroke.

Authors:  N Jacobs
Journal:  Eye (Lond)       Date:  2014-06-06       Impact factor: 3.775

3.  Iris angiographic findings in retinal arterial occlusions.

Authors:  M Kottow; P Hendrickson
Journal:  Can J Ophthalmol       Date:  1974-10       Impact factor: 1.882

4.  Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset.

Authors:  Adam K Rudkin; Andrew W Lee; Celia S Chen
Journal:  Eur J Ophthalmol       Date:  2010 Nov-Dec       Impact factor: 2.597

5.  Isolated central retinal artery obstruction in association with ocular neovascularization.

Authors:  G C Brown
Journal:  Am J Ophthalmol       Date:  1983-07       Impact factor: 5.258

6.  Central retinal artery occlusion. Retinal survival time.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Alan Kimura; Ashish Sanon
Journal:  Exp Eye Res       Date:  2004-03       Impact factor: 3.467

7.  Occlusion of the central retinal artery and ocular neovascularisation: an indirect association?

Authors:  N A Jacobs; D R Trew
Journal:  Eye (Lond)       Date:  1992       Impact factor: 3.775

8.  Letter to the editor: partial central retinal artery occlusion offers a unique insight into the ischemic penumbra.

Authors:  David McLeod
Journal:  Clin Ophthalmol       Date:  2011-12-29
  8 in total
  1 in total

Review 1.  Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.

Authors:  Francisco Barroso; João Crispim Ribeiro; Eduardo P Miranda
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.